Clolar and hypoxia Patient Reports February 13, 2012

Clolar Side Effects Report #6039500-X
Clolar side effect was reported by a Physician from UNITED STATES on Jan 06, 2009. Female patient, weighting 20.50 lb, was diagnosed with myeloid leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: acute graft versus host disease in skin, blood bilirubin increased, blood lactate dehydrogenase increased, cytomegalovirus viraemia, hypoxia, leukaemia recurrent, platelet count decreased, red blood cell count decreased, transaminases increased. Clolar dosage: 16.8 MG, QDX5, INTRAVENOUS. During the same period patient was treated with BUSULFAN, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.

Clolar Side Effects Report #6058028-4
Clolar side effect was reported by a Physician from UNITED STATES on Jan 16, 2009. Female patient, weighting 20.50 lb, was diagnosed with myeloid leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: acute graft versus host disease in liver, acute graft versus host disease in skin, blood lactate dehydrogenase increased, cytomegalovirus viraemia, hypoxia, infection , liver function test abnormal, platelet count decreased, pleural effusion. Clolar dosage: 16.8 MG, QDX5, INTRAVENOUS. During the same period patient was treated with BUSULFAN, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.

Clolar Side Effects Report #6024230-0
Clolar side effect was reported by a Physician from UNITED STATES on Dec 17, 2008. Female patient, 63 years of age, weighting 256.2 lb, was diagnosed with chronic myeloid leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hypoxia, staphylococcal infection . Clolar dosage: 71.7 MG, QDX5, INTRAVENOUS. During the same period patient was treated with BUSULFAN, MICAFUNGIN, METHYLPREDNISOLONE, TACROLIMUS, LEVOFLOXACIN, VANCOMYCIN HYDROCHLORIDE, MOMETASONE FUROATE. Patient was hospitalized. Patient recovered.

Clolar Side Effects Report #5614672-7
Clolar side effect was reported by a Physician from UNITED STATES on Jan 28, 2008. Male patient, 15 years of age, weighting 166.4 lb, was diagnosed with bone marrow conditioning regimen and was treated with Clolar. After drug was administered, patient experienced the following side effects: hypoxia, pulmonary embolism , thrombocytopenia. Clolar dosage: 38 MG, QDX5, INTRAVENOUS. During the same period patient was treated with HEPARIN, OXYGEN. Patient died on 01/13/2008.


Clolar Side Effects Report #6026604-0
Clolar side effect was reported by a Physician from UNITED STATES on Dec 24, 2008. Female patient, weighting 20.50 lb, was diagnosed with acute myeloid leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: acute graft versus host disease in skin, bone marrow transplant , cytomegalovirus viraemia, hypoxia, infection , transaminases increased, venoocclusive liver disease. Clolar dosage: 16.8 MG, QDX5, INTRAVENOUS. During the same period patient was treated with BUSULFAN. Patient was hospitalized. Patient recovered.

Clolar Side Effects Report #5720929-1
Clolar side effect was reported by a Physician from UNITED STATES on Apr 21, 2008. Male patient, 47 years of age, weighting 136.7 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: dialysis , enterococcal infection, hypoxia, neutropenic infection, refusal of treatment by relative, renal failure, respiratory failure, sepsis , staphylococcal infection . Clolar dosage: 40 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient died on 04/08/2008.

Clolar Side Effects Report #5738493-X
Clolar side effect was reported by a Physician from UNITED STATES on May 07, 2008. Male patient, 47 years of age, weighting 136.7 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: culture urine positive, dialysis , enterococcal infection, hypoxia, neutropenic infection, renal failure, respiratory failure, sepsis syndrome, staphylococcal infection . Clolar dosage: 40 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with CYTARABINE, CALCIUM ACETATE, DEXAMETHASONE PHOSPHATE, FLUCONAZOLE, ACETAMINOPHEN, ACYCLOVIR, ESCITALOPRAM. Patient died on 04/08/2008.

Clolar Side Effects Report #5694161-4
Clolar side effect was reported by a Physician from UNITED STATES on Mar 27, 2008. Female patient, 14 years of age, weighting 95.90 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: acute graft versus host disease, bronchopulmonary aspergillosis, gastrointestinal infection, hypoxia, respiratory distress, respiratory tract infection, urinary tract infection . Clolar dosage: 20 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with CYCLOSPORIN, DIPHENHYDRAMINE. Patient died on 03/14/2008.

Clolar Side Effects Report #6019901-6
Clolar side effect was reported by a Physician from UNITED STATES on Dec 17, 2008. Female patient, 14 years of age, weighting 96.78 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: acute graft versus host disease, alanine aminotransferase increased, aspartate aminotransferase increased, bronchopulmonary aspergillosis, convulsion, gastrointestinal infection, hypersensitivity, hypoxia, no therapeutic response. Clolar dosage: 27 MG, QDX5, INTRAVENOUS. During the same period patient was treated with AMPICILINA SULBACTAM, AZITHROMYCIN, MICAFUNGIN, PHENYTOIN, CYCLOSPORIN, DIPHENHYDRAMINE. Patient died on 03/14/2008.


Clolar Side Effects Report #6121977-2
Clolar side effect was reported by a Physician from UNITED STATES on Mar 04, 2009. Female patient, 65 years of age, weighting 231.5 lb, was diagnosed with acute leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: blast cells present, culture urine positive, decreased appetite, disease recurrence, enterococcal infection, hypoxia, orthostatic hypotension, pneumonia , pyrexia. Clolar dosage: 68 MG, QDX5, INTRAVENOUS. During the same period patient was treated with BUSULFAN. Patient was hospitalized. Patient died on 02/20/2009.

Clolar Side Effects Report #5583670-4
Clolar side effect was reported by a Physician from UNITED STATES on Dec 20, 2007. Male patient, child 12 years of age, was diagnosed with acute leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: chest pain , febrile neutropenia, gingival bleeding, heart rate increased, hypotension, hypoxia, infection , musculoskeletal pain, nausea . Clolar dosage: 36 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, NALOXONE, HYDROMORPHONE. Patient recovered.

Clolar Side Effects Report #5587640-1
Clolar side effect was reported by a Physician from UNITED STATES on Jan 02, 2008. Male patient, child 12 years of age, was diagnosed with acute leukaemia and was treated with Clolar. After drug was administered, patient experienced the following side effects: febrile neutropenia, gingival bleeding, hypotension, hypoxia, infection , musculoskeletal pain, nausea , pain in extremity, pericardial effusion. Clolar dosage: 36 MG, UNK, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, NALOXONE, HYDROMORPHONE. Patient recovered.

Clolar Side Effects Report #6120549-3
Clolar side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 12, 2009. Male patient, weighting 198.4 lb, was treated with Clolar. After drug was administered, patient experienced the following side effects: anaemia, dehydration, escherichia sepsis, febrile neutropenia, hypoxia, multi-organ failure, organising pneumonia, skin lesion, thrombocytopenia. Clolar dosage: 425 MG. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.